EP1448190A2 — Salts formed of an at1-receptor antagonist and a cardiovascular agent
Assigned to Novartis Pharma GmbH Austria · Expires 2004-08-25 · 22y expired
What this patent protects
The invention relates to a salt formed of at least one AT1-receptor antagonist having at least one acidic center and of at least one cardiovascular ingredient having at least one basic center that can be used for treating cardiovascular diseases and conditions, their prophylaxis …
USPTO Abstract
The invention relates to a salt formed of at least one AT1-receptor antagonist having at least one acidic center and of at least one cardiovascular ingredient having at least one basic center that can be used for treating cardiovascular diseases and conditions, their prophylaxis or delay of progression.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.